Jean-Christophe Tellier

TLDR

Jean-Christophe Tellier is CEO and Chair of the Executive Committee of UCB, a Brussels-based biopharmaceutical company listed on Euronext Brussels.

Background

Jean-Christophe Tellier joined UCB in 2011 and became Chief Executive Officer on 1 January 2015, leading the company's transition into a focused biopharmaceutical group with a portfolio centered on neurology and immunology. The UCB Board has proposed renewing his mandate as CEO and director for a further four-year term through 2030. Earlier in his career he held senior roles in the global pharmaceutical industry, including at Novartis and Bristol-Myers Squibb.